Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company will host the second annual Contemporary Landscapes in Muscle Biology Research Symposium (CLIMB) on Friday, May 30 th, 2025 ...

In a widely expected move, the Trump administration will not defend a Biden-era Securities and Exchange Commission (SEC) climate disclosure ...

SEC Davao reminds corporations to comply with the 2025 deadlines for online submission of Annual Financial Statements (AFS) ...

Malik, M.D., Ph.D., Cytokinetics' Executive Vice President of Research ... to Cytokinetics' business outlines in Cytokinetics ...

Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.

-Under the agreement, CRISPR Therapeutics will make an upfront payment of $25 million in cash and $70 million in equity to ...

As of March 31, 2025, the Company’s cash, cash equivalents and investments was $314.2 million. The Company expects that its cash, cash equivalents and investments, as of March 31, 2025, will fund its ...

Hicklin, Ph.D., President and Chief Executive Officer of Werewolf ... "Risk Factors" section of the Company's most recent Form 10-K filed with the Securities and Exchange Commission (SEC), and in ...

Although it has the logo of the PCO ... and to submit its business permit or registration with the Securities and Exchange Commission. In his memorandum, De Vera imposed the requirement ...

The BC Securities Commission says a Vancouver cryptocurrency firm has been temporarily banned from trading securities and ...

The Crypto Council for Innovation is making a case with the U.S. Securities and Exchange Commission that staking is not only a virtue for digital asset markets, but it should be hands-off for the ...